THE start of next month will see
the PBS listing of Actemra
(tocilizumab), which is the first
biologic treatment for rheumatoid
arthritis to be clinically superior to
methotrexate as monotherapy.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 21 Jul 10 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 21 Jul 10
HIGH rates of unnecessary prescribing reported in the Australian Institute of Health and Welfare (AIHW) Australia’s Health 2018 report highlights the need for greater integration of pharmacists in medication management roles, the Pharmaceutical Society of Australia (PSA) believes.